In accordance with the NMPA approval, Gyre intends to pursue an adaptive Phase 2/3 clinical trial design, combining dose exploration with efficacy confirmation, to efficiently evaluate pirfenidone's ...

While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...

NEWARK, CALIFORNIA / ACCESS Newswire / March 18, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company"), a clinical-stage biopharmaceutical company pioneering the discovery and ...

Lee este artículo en español. If you love great deals, fast shipping, and streaming movies and music, an Amazon Prime membership might be perfect for you. From electronics, digital entertainment, to ...

History already told us that it's highly likely two of the top leagues will have five places in the Champions League. Now that's been strengthened by the extra bonus points in the UCL. And we're ...

Shares in US biotech Five Prime Therapeutics more than tripled after it reported promising trial results with stomach cancer drug candidate bemarituzumab, returning the stock to levels not seen ...

OTTAWA — Mark Carney was sworn in Friday as Canada’s 24th prime minister in a ceremony in Rideau Hall, alongside his new cabinet. Here are five things to know about the new prime minister’s plans and ...

OTTAWA — Mark Carney was sworn in Friday as Canada’s 24th prime minister in a ceremony in Rideau Hall, alongside his new cabinet. Here are five things to know about the new prime minister’s ...

SAN FRANCISCO - Nurix Therapeutics, Inc. (NASDAQ ... The European Medicines Agency also granted PRIME designation for NX-5948 for chronic lymphocytic leukemia or small lymphocytic lymphoma.

To come up with the list, we considered only the stocks with at least $2 billion in market capitalization and $5 million in trading volume. Viking Therapeutics jumped by 11.43 percent on Wednesday ...

Copyright 2025 The Associated Press. All Rights Reserved. Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] “The Apprentice,” the long-running ...